ALK-Abello A/S operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Christian Hansen Holding with three other
pharmaceutical manufacturers in Europe:
sales of 22.85 million Euro [US$25.47 million]
of which 96%
was Product Sales),
(8.73 million Euro [US$9.73 million]
of which 72%
was Research & Development Tax Credit), and
Biomed Lublin Wytwornia Surowic I Szczepionek SA
based in Poland
(36.34 million Polish New Zlotys [US$9.60 million]
of which 76%
was Traditional Segment).
Christian Hansen Holding reported sales of 3.01 billion Danish Kroner (US$450.39 million)
December of 2016.
increase of 17.0%
versus 2015, when the company's sales were 2.57 billion Danish Kroner.
This was the third consecutive year of growth at Christian Hansen Holding.
Sales of Scit/slit Drops saw an increase
18.7% in 2016, from
1.85 billion Danish Kroner to 2.19 billion Danish Kroner.